Login/Sign Up
MRP ₹29750
(Inclusive of all Taxes)
₹4462.5 Cashback (15%)
Provide Delivery Location
Therapeutic Class
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Alcohol
Safe if prescribed
Limited information is available. Please consult your doctor.
Pregnancy
Consult your doctor
Please consult your doctor if you are pregnant. Your doctor will prescribe only if the potential benefits outweigh the potential risk to the foetus.
Breast Feeding
Consult your doctor
Please consult your doctor if you are breastfeeding. Caution should be exercised whilst administering Cathlyse 18 Injection to a nursing mother.
Driving
Safe if prescribed
Limited information is available. Please consult your doctor.
Liver
Consult your doctor
The potential risks with the therapy of Cathlyse 18 Injection may be increased in patients with severe liver dysfunction and should be weighed against the anticipated benefits. Please consult your doctor.
Kidney
Consult your doctor
The potential risks of Cathlyse 18 Injection therapy may be increased in patients with severe renal dysfunction and should be weighed against the anticipated benefits. Please consult your doctor.
Children
Safe if prescribed
The efficacy and safety of Cathlyse 18 Injection in children have not been established.
Product Substitutes
About Cathlyse 18 Injection
Cathlyse 18 Injection is a tissue plasminogen activator indicated for the treatment of acute ST-elevation myocardial infarction (STEMI) to lower the risk of heart failure and death. STEMI is a very serious type of heart attack that occurs due to blockage of the heart’s major arteries.
Cathlyse 18 Injection contains Reteplase, which works by dissolving the blood clot that is blocking the heart blood vessel.
In some cases, Cathlyse 18 Injection may cause side effects such as bleeding, bruising at the injection site, nausea or vomiting. You are advised to talk to your doctor if any of the side effects persist or worsen.
Consult your doctor if you are pregnant or breastfeeding. The efficacy and safety of Cathlyse 18 Injection in children have not been established. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.
Uses of Cathlyse 18 Injection
Key Benefits
Cathlyse 18 Injection is a tissue plasminogen activator indicated for the treatment of acute ST-elevation myocardial infarction (STEMI) to reduce the risk of heart failure and death. Cathlyse 18 Injection contains Reteplase that works by dissolving the blood clot that is blocking the heart blood vessel. It may also be indicated in the treatment of a recent left bundle branch block (a delay/blockage of electrical impulses to the left side of the heart).
Directions for Use
Side Effects of Cathlyse 18 Injection
Drug Warnings
Cathlyse 18 Injection should not be used if you are allergic to any of the components in Cathlyse 18 Injection, in patients with active internal bleeding, recent stroke, recent intracranial or intraspinal surgery or serious head trauma, intracranial neoplasm (brain tumour), arteriovenous malformation, or aneurysm (ballooning and weakened area in an artery), known bleeding diathesis (tendency to bleed or bruise easily), or severe uncontrolled hypertension. Cathlyse 18 Injection may cause bleeding, hypersensitivity reactions, or cholesterol embolism. Inform your doctor if you have/had recent major surgery, cerebrovascular disease, recent gastrointestinal/genitourinary bleeding, hypertension, subacute bacterial endocarditis, severe hepatic or renal disease, if you are over 75 years or if you are taking any oral anticoagulants. Consult your doctor if you are pregnant or breastfeeding. The safety and effectiveness of Cathlyse 18 Injection in children have not been established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
Login/Sign Up
Drug-Drug Interactions Checker List
Habit Forming
Diet & Lifestyle Advise
RXEmcure Pharmaceuticals Ltd
₹28333.32
(₹23233.32 per unit)
RXCipla Ltd
₹36300
(₹29766.0 per unit)
RXReliance Formulation Pvt Ltd
₹40491.5
(₹33203.0 per unit)

Have a query?